INTRODUCTION

Benzofuran
1 compounds are ubiquitous in nature, particularly among plant kingdom. Often such natural products possessing benzofuran nucleus are endowed with useful pharmacological properties. This has generated enormous interest in synthetic products containing benzofuran nucleus and has resulted in the development of benzofuran chemistry during the last several years. Benzofurans are bicyclic ring system with multiple applications. The Literature indicates that compounds having Benzofuran 2 nucleus possess broad range of biological activities, like Griseofulvin as antifungal; Amiodarone as antiarrythmic; Benzbromarone as uricosuric; Cloridarol as vasodilator; Oxetorone as antimigraine agent.
Pyrazolines are nitrogen-containing heterocyclic compounds, well known for their pronounced biological activity. These biological activities include antibacterial 3 , antifungal 4 , herbicidal 5 and insecticidal activities 6 . It was demonstrated that the combination of pyrazole with azole ring, linked to each by one sigma bond, led to more biologically active targets; for example, pyrazolylthiazoles showed excellent antimicrobial activities 7 . Pyrazole 8 derivatives have a long history of application in Agrochemicals and Pharmaceutical industry as herbicides and active pharmaceuticals. The wide variety of Nitrogen containing heterocyclic compounds that have been exploited to develop pharmaceutically important molecules such as Pyrazole and their derivatives are important due to their diverse biological activities such as anti-fungal 9 , anti-bacterial 10 and others. The prevalence of pyrazole cores in biologically active molecules has stimulated the need for elegant and efficient ways to make these heterocyclic lead. These findings encourage us to undertake the synthesis of pyrazolene-benzofuran ring system, in the hope that they could have some promising biological interest.
II. MATERIALS AND METHODS
The synthesized compounds were screened for their anti-bacterial and anti-fungal activities. The various screenings carried out include the in vitro study against Gram positive Staphylococcus aureus ATCC 3750, Gram negative Salmonella typhi NCTC 786 and fungal strain Candida albicans and Aspergillus niger. The Minimum Inhibitory Concentration (MIC) was determined using tube dilution method according to the standard procedure 11 . DMSO was used as a solvent with appropriate controls. Ampicillin (MIC = 0.01 µg/ml against Gram positive S. aureus), Trimethoprim (MIC = 1 µg/ml against Gram negative S. typhi) were used as standard drugs for anti-bacterial screening and Miconazole was used as anti-fungal standard drug (MIC = 0.01 µg/ml). 
Synthesis of 5-bromo-2-cinnamoyl-3-methyl Benzofuran (ll)
5-Bromo-2-acetylbenzofuran (l) 2.52g (0.01 mole) was stirred in 10ml of anhydrous ethyl alcohol. 1.40g (0.01 mole) of 3-chlorobenzaldehyde was added to the reaction mixture at room temperature. This reaction mixture was cooled for 3 hours and contents allowed standing overnight. The solution was diluted with water and neutralized with dilute HCl. The off-white colored solid thus separated was collected, dried and crystallized from ethanol.
Yield: 55%, M 
Synthesis of 5-(3-Chlorophenyl)-3-(5-bromo-3-methylbenzofuran-2-yl-1H-pyrazolines (lll)
A mixture of 3.91g (0.01 mole) of 5-Chloro-2-cinnamoyl-3-methyl benzofuran (ll) and 2.5g (0.15 mole) of hydrazine hydrate in 50ml anhydrous ethanol was refluxed for 3 hours. Excess of solvent was distilled off. Pour on to crush ice, solids collected. Product crystallized from ethanol.
Yield 1 (2H,s), 3.1 (1H,s) of [ 3-(5-bromo-3-methyl-1-benzofuran-2-yl)-5-(4-chlorophenyl)-4,5-dihydro-1H pyrazol-1-yl](2,4-dimethoxyphenyl) -3-methyl-1-benzofuran-2-yl)-5-(4-chlorophenyl) IV.
Synthesis of [ 3-(5-bromo-3-methyl-1-benzofuran-2-yl)-5-(4-chlorophenyl)-4,5-dihydro-1H pyrazol-1-yl](3-fluorophenyl) methanone
Synthesis of [ 3-(5-bromo-3-methyl-1-benzofuran-2-yl)-5-(4-chlorophenyl)-4,5-dihydro-1H pyrazol-1-yl](4-Hydroxyphenyl) methanone
Synthesis
Synthesis of [ 3-(5-bromo
RESULTS
All the eight synthesized compounds (Table No. 2) showed moderate activity upto 200 µg/ml among which 4-Hydroxy and 2, 4-Dimethoxy (Sr. no. 4& 5) showed activity upto 50 µg/ml against Staphylococcus aureus. The 4-fluoro derivative (Sr. no. 3) exhibited activity at 100µg/ml while the other remaining compounds exhibited activity upto 200 µg/ml against Salmonella typhi.
All the compounds showed moderate activity against fungal species of Candida albicans upto 100 µg/ml exceptional of 2,4-Dimethoxy substitutions (Sr. no.5) with activity at 200 µg/ml. The compounds with 4-fluoro substitution (Sr. no 3) showed activity at 100 µg/ml while remaining others showed activity at 200 µg/ml against Aspergillus niger species except 2,4-Dimethoxy substitutions (compound no. 305) which is found inactive upto 200 µg/ml.
DISCUSSION
The purpose of the present study was to examine whether molecular modifications might result in detection of new potential anti-microbial drugs. A series of compounds were prepared and assayed in variety of biological tests for anti-microbial activity. The data reported in table 2 shows that the effect of variation in chemical structure on activity was rather unpredictable. The substitution which appeared to be the most important for higher order of activity in the greatest number was test for p-chloroaryl group. The introduction of P-methoxy and P-hydroxy in aryl moiety of the pyrazole analogs produced compounds with anti-microbial properties.
V. CONCLUSION
In conclusion, the results of this investigation revealed that the observed substitution at Para position is better for enhancing anti-microbial activity. Obviously, the comparative evaluation of active compounds will require further studies; the data reported in this article may be a helpful guide for medicinal chemists.
